Stockreport

Kymera Therapeutics price target raised to $140 from $125 at Piper Sandler [Yahoo! Finance]

Kymera Therapeutics, Inc.  (KYMR) 
PDF Piper Sandler analyst Biren Amin raised the firm's price target on Overweight-rated Kymera Therapeutics ( KYMR ) to $140 from $125 after transfer in analyst coverage. T [Read more]